Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Revenue

Corcept Therapeutics had revenue of $182.55M in the quarter ending September 30, 2024, with 47.69% growth. This brings the company's revenue in the last twelve months to $628.56M, up 39.67% year-over-year. In the year 2023, Corcept Therapeutics had annual revenue of $482.38M with 20.04% growth.

• Revenue (ttm): $628.56M
• Revenue Growth: +39.67%
• P/S Ratio: 10.96
• Revenue / Employee: $1,785,668
• Employees: 352
• Market Cap: 7.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	482.38M	80.52M	20.04%
Dec 31, 2022	401.86M	35.88M	9.80%
Dec 31, 2021	365.98M	12.10M	3.42%
Dec 31, 2020	353.87M	47.39M	15.46%
Dec 31, 2019	306.49M	55.24M	21.99%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.